Daniels G. Human blood groups. 3rd ed. Oxford: Blackwell Science, 2013.DanielsG.3rd ed.Oxford: Blackwell Science, 2013.10.1002/9781118493595Search in Google Scholar
Roback JD, Combs MR, Grossman BJ, Hillyer CD. Technical manual: advancing transfusion and cellular therapies worldwide. Bethesda, MD: AABB, 2008.RobackJDCombsMRGrossmanBJHillyerCD.Bethesda, MD: AABB, 2008.Search in Google Scholar
Lei YM, Nair L, Alegre ML. The interplay between the intestinal microbiota and the immune system. Clin Res Hepatol Gastroenterol 2015;39:9–19.LeiYMNairLAlegreML.The interplay between the intestinal microbiota and the immune system. 2015;39:9–19.10.1016/j.clinre.2014.10.008442378625481240Search in Google Scholar
Perry HE, Franklin RA, Bray SJ, Lo MK, Svensson LA, Henry SM. A novel study of association between Neisseria gonorrhoeae and the human carbohydrate blood groups. Immunohematology 2007;23:100–4.PerryHEFranklinRABraySJLoMKSvenssonLAHenrySM.A novel study of association between Neisseria gonorrhoeae and the human carbohydrate blood groups. 2007;23:100–4.10.21307/immunohematology-2019-327Search in Google Scholar
Wu AM, Wu JH, Singh T, Liu JH, Tsai MS, Gilboa-Garber N. Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes. Biochimie 2006;88:1479–92.WuAMWuJHSinghTLiuJHTsaiMSGilboa-GarberN.Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes. 2006;88:1479–92.10.1016/j.biochi.2006.05.00416762477Search in Google Scholar
Palm NW, de Zoete MR, Flavell RA. Immune-microbiota interactions in health and disease. Clin Immunol 2015;159: 122-127.PalmNWde ZoeteMRFlavellRA.Immune-microbiota interactions in health and disease. 2015;159: 122–127.10.1016/j.clim.2015.05.014494304126141651Search in Google Scholar
Santos CM, Pires MC, Leão TL, et al. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment. Microbiology 2016;162:1195–207.SantosCMPiresMCLeãoTLSelection of Lactobacillus strains as potential probiotics for vaginitis treatment. 2016;162:1195–207.10.1099/mic.0.00030227154285Search in Google Scholar
Bouhnik Y, Raskine L, Simoneau G, et al. The capacity of non-digestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 2004;80:1658–64.BouhnikYRaskineLSimoneauGThe capacity of non-digestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. 2004;80:1658–64.10.1093/ajcn/80.6.165815585783Search in Google Scholar
Garro MS, Aguirre L, Giori GS. Biological activity of Bifidobacterium longum in response to environmental pH. Appl Microbiol Biotechnol 2005;70:612–7.GarroMSAguirreLGioriGS.Biological activity of Bifidobacterium longum in response to environmental pH. 2005;70:612–7.10.1007/s00253-005-0102-y16088351Search in Google Scholar
Brasil. Ministério da Saúde. Portaria de Consolidação n. 5, de 28 de setembro de 2017. Brasília: Ministério da Saúde, 2017.BrasilBrasília: Ministério da Saúde, 2017.Search in Google Scholar
Girello AL, Kühn TIBB. Fundamentos da imunohema-tologiaeritrocitária. 4th ed. São Paulo, SP: Senac, 2014.GirelloALKühnTIBB.4th edSão Paulo, SP: Senac2014.Search in Google Scholar
Judd WJ, Johnson ST, Storry JR. Judd’s methods in immunohematology. 3rd ed. Bethesda, MD: AABB Press, 2008:557–9.JuddWJJohnsonSTStorryJR.3rd edBethesda, MD: AABB Press, 2008:557–9.Search in Google Scholar
Scardovi V. Genus Bifidobacterium. In: Bergey’s manual of systematic bacteriology. Baltimore, MD: Williams and Wilkins, 1986:1418–34.ScardoviV.Genus Bifidobacterium in Baltimore, MD: Williams and Wilkins, 1986:1418–34.Search in Google Scholar
Orban JI, Patterson JA. Modification of the phosphoketolase assay for rapid identification of bifidobacterias. J Microbiol Methods 2000;40:221–4.OrbanJIPattersonJA.Modification of the phosphoketolase assay for rapid identification of bifidobacterias. 2000;40:221–4.10.1016/S0167-7012(00)00133-0Search in Google Scholar
Vinderola CG, Reinheimer JA. Enumeration of Lactobacillus casei in the presence of Lactobacillus acidophilus and lactic starter in fermented dairy products. Int. Dairy J 2000;10: 271–5.VinderolaCGReinheimerJA.Enumeration of Lactobacillus casei in the presence of Lactobacillus acidophilus and lactic starter in fermented dairy products. 2000;10:271–5.10.1016/S0958-6946(00)00045-5Search in Google Scholar
Maldonado Galdeano C, Cazorla SI, Lemme Dumit JM, Vélez E, Perdigón G. Beneficial effects of probiotic consumption on the immune system. Ann Nutr Metab 2019;74:115–24.Maldonado GaldeanoCCazorlaSILemme DumitJMVélezEPerdigónG.Beneficial effects of probiotic consumption on the immune system. 2019;74:115–24.10.1159/00049642630673668Search in Google Scholar
Check JH, O’Neill EA, O’Neill KE, Fuscaldo KE. Effect of anti-B antiserum on the phagocytosis of Escherichia coli. Infect Immun 1972;6:95–6.CheckJHO’NeillEAO’NeillKEFuscaldoKE.Effect of anti-B antiserum on the phagocytosis of Escherichia coli. 1972;6:95–6.10.1128/iai.6.1.95-96.19724224964564154Search in Google Scholar
Garratty, G. Blood groups and disease: a historical perspective. Transfus Med Rev 2012;14:291–301.GarrattyG.Blood groups and disease: a historical perspective. 2012;14:291–301.10.1053/tmrv.2000.1622811055074Search in Google Scholar
Yamamoto F, Cid E, Yamamoto M, Blancher A. ABO research in the modern era of genomics. Transfus Med Rev 2012;26: 103–18.YamamotoFCidEYamamotoMBlancherA.ABO research in the modern era of genomics. 2012;26: 103–18.10.1016/j.tmrv.2011.08.00221945157Search in Google Scholar
Ewald DR, Sumner SC. Blood type biochemistry and human disease. Wiley Interdiscip Rev Syst Biol Med 2016;8:517–535.EwaldDRSumnerSC.Blood type biochemistry and human disease. 2016;8:517–535.10.1002/wsbm.1355506161127599872Search in Google Scholar
Gampa A, Engen PA, Shobar R, Mutlu EA. Relationships between gastrointestinal microbiota and blood group antigens. Physiol Genomics 2017;49:473–83.GampaAEngenPAShobarRMutluEA.Relationships between gastrointestinal microbiota and blood group antigens. 2017;49:473–83.10.1152/physiolgenomics.00043.2017562527228710295Search in Google Scholar
Daniel-Johnson J, Leitman S, Klein H, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009;49:1845–9.Daniel-JohnsonJLeitmanSKleinHProbiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. 2009;49:1845–9.10.1111/j.1537-2995.2009.02208.x342102619453987Search in Google Scholar
Karafin MS, Blagg L, Tobian AA, King KE, Ness PM, Savage WJ. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion 2012;52:2087–93.KarafinMSBlaggLTobianAAKingKENessPMSavageWJ.ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. 2012;52:2087–93.10.1111/j.1537-2995.2012.03574.x336013722339320Search in Google Scholar
Mäkivuokko H, Lahtinen SJ, Wacklin P, et al. Association between the ABO blood group and the human intestinal microbiota composition. BMC Microbiol 2012;6:12–94.MäkivuokkoHLahtinenSJWacklinPAssociation between the ABO blood group and the human intestinal microbiota composition. 2012;6:12–94.10.1186/1471-2180-12-94348515922672382Search in Google Scholar
Davenport ER, Goodrich JK, Bell JT, Spector TD, Ley RE, Clark AG. ABO antigen and secretor statuses are not associated with gut microbiota composition in 1,500 twins. BMC Genomics 2016;17:941.DavenportERGoodrichJKBellJTSpectorTDLeyREClarkAG.ABO antigen and secretor statuses are not associated with gut microbiota composition in 1,500 twins. 2016;17:941.10.1186/s12864-016-3290-1511760227871240Search in Google Scholar
Springer GF, Williamson P, Brandes WC. Blood group activity of Gram-negative bacteria. J Exp Med 1961;113:1077–93.SpringerGFWilliamsonPBrandesWC.Blood group activity of Gram-negative bacteria. 1961;113:1077–93.10.1084/jem.113.6.1077213742319867191Search in Google Scholar
Schenkel-Brunner H. Human blood groups. Chemical and biochemical basis of antigen specificity. 2nd ed. New York: Springer, 2000.Schenkel-BrunnerH.Human blood groups. 2nd ed.New York: Springer, 2000.Search in Google Scholar
Yamamoto F. Review: ABO blood group system—ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology 2004;20:3–22.YamamotoF.Review: ABO blood group system—ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. 2004;20:3–22.10.21307/immunohematology-2019-418Search in Google Scholar
Gomes NM, de Souza NB, Cruz, AB, Valcarenghi D, Geraldo A. Ação bactericida de isoaglutininas ABO em diferentes diluições de anticorpos anti-ABO. Revista de Biotecnologia & Ciência. 2021;10:38–53.GomesNMde SouzaNBCruzABValcarenghiDGeraldoA.Ação bactericida de isoaglutininas ABO em diferentes diluições de anticorpos anti-ABO. 2021;10:38–53.10.31668/rbc.v10i2.12580Search in Google Scholar
Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009;25:48–59.StorryJROlssonML.The ABO blood group system revisited: a review and update. 2009;25:48–59.10.21307/immunohematology-2019-231Search in Google Scholar
Franchini M, Bonfanti C. Evolutionary aspects of ABO blood group in humans. Clin Chim Acta 2015;444:66–71.FranchiniMBonfantiC.Evolutionary aspects of ABO blood group in humans. 2015;444:66–71.10.1016/j.cca.2015.02.01625689219Search in Google Scholar
Mukherjee AP. Hypothesis: Immunotherapy by selective convalescent blood engineering to stifle diseases like COVID-19. Int J Med Sci 2021;18:3389–94.MukherjeeAP.Hypothesis: Immunotherapy by selective convalescent blood engineering to stifle diseases like COVID-19. 2021;18:3389–94.10.7150/ijms.46363843610234522165Search in Google Scholar
Stowell SR, Arthur CM, Dias-Baruffi M, et al. Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 2010;16:295–301.StowellSRArthurCMDias-BaruffiMInnate immune lectins kill bacteria expressing blood group antigen. 2010;16:295–301.10.1038/nm.2103285318120154696Search in Google Scholar
Ewald DR, Sumner SCJ. Human microbiota, blood group antigens, and disease. Wiley Interdiscip Rev Syst Biol Med 201;10:e1413.EwaldDRSumnerSCJ.Human microbiota, blood group antigens, and disease. 201;10:e1413.10.1002/wsbm.1413590242429316320Search in Google Scholar
Uchida H, Kinoshita H, Kawai Y, et al. Lactobacilli binding human A-antigen expressed in intestinal mucosa. Res Microbiol 2006;157:659–65.UchidaHKinoshitaHKawaiYLactobacilli binding human A-antigen expressed in intestinal mucosa. 2006;157:659–65.10.1016/j.resmic.2006.03.00116631357Search in Google Scholar
WHO – World Health Organization Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO): Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk and live lactic bacteria. Available from: https://www.fao.org/publications/card/fr/c/7c102d95-2fd5-5b22-8faf-f0b2e68dfbb6/2006. Accessed 28 June 2022.. Available fromhttps://www.fao.org/publications/card/fr/c/7c102d95-2fd5-5b22-8faf-f0b2e68dfbb6/2006Accessed 28 June 2022.Search in Google Scholar
Milajerdi A, Mousavi SM, Sadeghi A, et al. The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. Eur J Nutr 2020;59:633–49.MilajerdiAMousaviSMSadeghiAThe effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. 2020;59:633–49.10.1007/s00394-019-01931-830854594Search in Google Scholar
Tesser HC, Bueno EC, Nesello AN, Geraldo A. Avaliação do consumo e percepção dos efeitos dos probióticos por universitários com diferentes fenótipos ABO. R Bras Tecnol Agroindustr 2020;14:3418–34.TesserHCBuenoECNeselloANGeraldoA.Avaliação do consumo e percepção dos efeitos dos probióticos por universitários com diferentes fenótipos ABO. 2020;14:3418–34.10.3895/rbta.v14n2.11335Search in Google Scholar
Czerwiński M. Grupy. [Blood groups – minuses and pluses. Do the blood group antigens protect us from infectious diseases?] [in Polish]. Postepy Hig Med Dosw 2015;25:703–22.CzerwińskiM.Grupy. [Blood groups – minuses and pluses. Do the blood group antigens protect us from infectious diseases?] [in Polish]. 2015;25:703–22.10.5604/17322693.115879526206987Search in Google Scholar
Gilmiyarova FN, Kolotyeva NA, Kuzmicheva VI, et al. [Blood group and human diseases (review of literature)]. [in Russian]. Klin Lab Diagn 2020;65:216–21.GilmiyarovaFNKolotyevaNAKuzmichevaVI[Blood group and human diseases (review of literature)]. [in Russian]. 2020;65:216–21.10.18821/0869-2084-2020-65-4-216-22132227726Search in Google Scholar
Bailey JD, Fisher AD, Yazer MH, et al. Changes in donor antibody titer levels over time in a military group O low-titer whole blood program. Transfusion 2019;59(S2):1499–506.BaileyJDFisherADYazerMHChanges in donor antibody titer levels over time in a military group O low-titer whole blood program. 2019;59:S21499–506.10.1111/trf.1516230980742Search in Google Scholar
Koch EJ, Snow R, Cook JT, Wickman D, Lee J, Zarow GJ. Variation of anti-A and anti-B titers in group O potential blood donors: a pilot study. J Trauma Acute Care Surg 2021;1;91(2S Suppl 2):221–5.KochEJSnowRCookJTWickmanDLeeJZarowGJ.Variation of anti-A and anti-B titers in group O potential blood donors: a pilot study. 20211, 91:2S Suppl 2221–5.10.1097/TA.000000000000327434001714Search in Google Scholar